Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

How I treat primary ITP in adult patients who are unresponsive to or dependent on corticosteroid treatment

Waleed Ghanima, Terry Gernsheimer, David J Kuter

Blood blood.2021010968.

DOI: https://doi.org/10.1182/blood.2021010968

Published: 2021

Journal Articles

Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter study

Clinical Trials & Observations Brief Report

Marc Michel, Marco Ruggeri, Tomas Jose Gonzalez-Lopez, Salam Alkindi, Stéphane Cheze, Waleed Ghanima, Tor Henrik Anderson Tvedt, Mikael Ebbo, Louis Terriou, James B. Bussel, Bertrand Godeau

Blood (2020) 136 (26): 3056–3061.

DOI: https://doi.org/10.1182/blood.2020007594

Published: 2020

Journal Articles

ITP World Impact Survey (I-WISh) 2.0: Further Exploration of the Impact of ITP on Patients

Waleed Ghanima, Drew Provan, Nichola Cooper, MD, Axel Matzdorff, MDPhD, Ming Hou, Cristina Santoro, Mervyn Morgan, Caroline Kruse, Francesco Zaja, Leron Lahav, Yoshiaki Tomiyama, Michal Winograd, Barbara Lovrencic, Tom Bailey, MSci, Jens Haenig, James B. Bussel

Blood (2020) 136 (Supplement 1): 2–3.

DOI: https://doi.org/10.1182/blood-2020-136651

Published: 2020

Journal Articles

A Phase II Study to Assess the Sustained Response Off Treatment in Patients with ITP Receiving Eltrombopag, Who Had a Previous Insufficient Response to Corticosteroids (TAPER): A Recruitment Update

Nichola Cooper, MD, Waleed Ghanima, Jens Haenig, James Lee, Masiur Rahman, Francesco Zaja

Blood (2020) 136 (Supplement 1): 37–38.

DOI: https://doi.org/10.1182/blood-2020-137398

Published: 2020

Journal Articles

Magnetic resonance imaging for diagnosis of recurrent ipsilateral deep vein thrombosis

Clinical Trials & Observations

Blood (2020) 135 (16): 1377–1385.

DOI: https://doi.org/10.1182/blood.2019004114

Published: 2020

Includes: Multimedia, Supplemental data

Journal Articles

Physicians' and Patients' Perspectives on Treatments in ITP - a Multi-Country Perspective: Results from the ITP World Impact Survey (I-WISh)

James B. Bussel, MD, Waleed Ghanima, MD PhD, Yoshiaki Tomiyama, MD, Donald M. Arnold, MD, Drew Provan, MD, Ming Hou, MD PhD, Cristina Santoro, MD PhD, Serge Laborde, Alexandra Kruse, Caroline Kruse, Mervyn Morgan, Barbara Lovrencic, John Waller, PhD, Jens Haenig, Nichola Cooper, MD MRCP

Blood (2019) 134 (Supplement_1): 1097.

DOI: https://doi.org/10.1182/blood-2019-130591

Published: 2019

Journal Articles

Enhanced Responses to Fostamatinib As Second-Line Therapy and in Persistent Immune Thrombocytopenia (ITP) Patients

Ralph Boccia, MD, Michael A. Boxer, MD, Waleed Ghanima, MD PhD, Quentin A. Hill, Michelle Sholzberg, MDBSc,FRCPC,MSc, Michael D. Tarantino, MD, Yuliya Kreychman, PharmD, Robert P. Numerof, PhD, Brian Olender, BA, Leslie Todd, Sandy Tong, MD, Anne-Marie Duliege, MDMS, Nichola Cooper, MD MRCP, James B. Bussel, MD

Blood (2019) 134 (Supplement_1): 1069.

DOI: https://doi.org/10.1182/blood-2019-126473

Published: 2019

Journal Articles

Safety and Efficacy of the Off-Label Use of Thrombopoietin Receptor Agonists for Immune Thrombocytopenia in Pregnancy: Results from a Multicentre Observational Study

Marc Michel, Marco Ruggeri, Tomás José González-López, MD, Stephane Cheze, MD, Waleed Ghanima, MD PhD, Tor Henrik Anderson Tvedt, Mikael Ebbo, MD PhD, James B. Bussel, MD, Bertrand Godeau, MD

Blood (2019) 134 (Supplement_1): 1081.

DOI: https://doi.org/10.1182/blood-2019-122595

Published: 2019

Journal Articles

The Psychometric Properties of the ITP Life Quality Index Assessed in a Large Multinational "Real-World" Cohort of Immune Thrombocytopaenia Patients

Philip Griffiths, Laura Grant, Nicola Bonner, MSc, Denise D'Alessio, MBA, Quentin A. Hill, Drew Provan, MD, Waleed Ghanima, MD PhD, Nichola Cooper, MD MRCP, Ricardo Viana, PhD

Blood (2019) 134 (Supplement_1): 386.

DOI: https://doi.org/10.1182/blood-2019-125766

Published: 2019

Journal Articles

Rituximab Yielded a Significantly Longer Response Compared to Placebo in Steroid Free Population - a Post Hoc Analysis of the Ritp Study

Waleed Ghanima, MD PhD, Marc Michel, Abderrahim Khelif, Bernadette Darne, Pal André Holme, PhDMD

Blood (2019) 134 (Supplement_1): 2358.

DOI: https://doi.org/10.1182/blood-2019-126975

Published: 2019

Journal Articles

The Risk of Thromboembolism Associated with Treatment of ITP with Rituximab: Adverse Event Reported in Two Randomized Controlled Trials

Lamya Garabet, Pal André Holme, PhDMD, Bernadette Darne, Abderrahim Khelif, Tor Henrik Anderson Tvedt, MD, Marc Michel, Waleed Ghanima, MD PhD

Blood (2019) 134 (Supplement_1): 4892.

DOI: https://doi.org/10.1182/blood-2019-126974

Published: 2019

Journal Articles

Long Term Remission Achieved By Fostamatinib in ITP: A Case Report

Waleed Ghanima, MD PhD, Tjønnfjord Eirik, MD PhD

Blood (2019) 134 (Supplement_1): 4901.

DOI: https://doi.org/10.1182/blood-2019-128359

Published: 2019

Journal Articles

Results from the ITP World IMPACT Survey (I-WISh): Patients with Immune Thrombocytopenia (ITP) Experience Impaired Quality of Life (QoL) Regarding Daily Activities, Social Interactions, Emotional Well-Being and Working Lives

Nichola Cooper, MRCP, Alexandra Kruse, Caroline Kruse, Shirley Watson, Mervyn Morgan, James B. Bussel, MD, Waleed Ghanima, Donald M. Arnold, MD MSc, FRCPC, Cristina Santoro, Ming Hou, MD, Yoshiaki Tomiyama, MD, Serge Laborde, Barbara Lovrencic, John Waller, PhD BSc, Tom Bailey, Gavin Taylor-Stokes, Miona Stankovic, Andrew Provan

Blood (2018) 132 (Supplement 1): 4804.

DOI: https://doi.org/10.1182/blood-2018-99-112858

Published: 2018

Journal Articles

Thrombin-Generating Capacity of Microvesicles (MVs) in Patients with Immune Thrombocytopenia (ITP) before and during Treatment with Thrombopoietin-Receptor Agonists (TPO-RA)

Lamya Garabet, Waleed Ghanima, MD PhD, Marit Hellum, Per Morten Sandset, James B. Bussel, MD, Carola E. Henriksson

Blood (2018) 132 (Supplement 1): 2511.

DOI: https://doi.org/10.1182/blood-2018-99-116911

Published: 2018

Journal Articles

Safety of D-Dimer As a Stand-Alone Test for the Exclusion of Deep Vein Thrombosis Compared to Other Strategies

Synne Fronas, MD, Hilde Skuterud Wik, Anders EA Dahm, MD PhD, Camilla Tøvik Jørgensen, Jostein Gleditsch, Nezar Raouf, Erik A Klok, MD PhD, Waleed Ghanima

Blood (2018) 132 (Supplement 1): 2517.

DOI: https://doi.org/10.1182/blood-2018-99-113831

Published: 2018

Journal Articles

Patients with Immune Thrombocytopenia (ITP) Frequently Experience Severe Fatigue but Is It Under-Recognized By Physicians: Results from the ITP World Impact Survey (I-WISh)

Caroline Kruse, Alexandra Kruse, Shirley Watson, Mervyn Morgan, Nichola Cooper, MRCP, Waleed Ghanima, Andrew Provan, Donald M. Arnold, MD MSc, FRCPC, Cristina Santoro, Ming Hou, MD, Yoshiaki Tomiyama, MD, Serge Laborde, Barbara Lovrencic, John Waller, PhD BSc, Gavin Taylor-Stokes, Tom Bailey, Miona Stankovic, James B. Bussel, MD

Blood (2018) 132 (Supplement 1): 2273.

DOI: https://doi.org/10.1182/blood-2018-99-112378

Published: 2018

Journal Articles

Romiplostim Treatment Pattern of Adult Chronic Immune Thrombocytopenia in Routine Clinical Care in Three Nordic Countries

Mette Nørgaard, Nickolaj Risbo Kristensen, Henrik Frederiksen, MD PhD, Shahram Bahmanyar, Waleed Ghanima, MD PhD, Naufil Alam, Anne Gulbech Ording, Henrik Toft Sørensen, Christian Fynbo Christiansen

Blood (2018) 132 (Supplement 1): 4998.

DOI: https://doi.org/10.1182/blood-2018-99-110965

Published: 2018

Journal Articles

Long-Term Maintenance of Platelet Responses in Adult Patients with Persistent/Chronic Immune Thrombocytopenia Treated with Fostamatinib: 1-Year Efficacy and Safety Results

James B. Bussel, MD, Donald M Arnold, MD, Nichola Cooper, MA, MD MRCP, FRCPath, Alhossain A Khalafallah, MD, Michael Boxer, MD, Darla Liles, MD, Waleed Ghanima, MD PhD, Keith McCrae, MD, Hany Zayed, Benoit Cadieux, PhD, Anne-Marie Duliege, MDMS

Blood (2017) 130 (Supplement 1): 16.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.16.16

Published: 2017

Journal Articles

Epidemiology of Myeloproliferative Neoplasms in Norway

Christina Roaldsnes, RN, Anders Waage, MD PhD, Mette Nørgaard, MD PhD, Waleed Ghanima, MDPhD

Blood (2014) 124 (21): 1858.

DOI: https://doi.org/10.1182/blood.V124.21.1858.1858

Published: 2014

Journal Articles

A Retrospective Cohort Study of Interferon-α Therapy in Myeloproliferative Neoplasms; Adverse Events, Thromboembolic Incidence and Causes of Termination of Therapy

Marie Lindgren, MD, Jan Samuelsson, MD PhD, Lars Nilsson, MD PhD, Håvar Knutsen, MD, Waleed Ghanima, MDPhD, Maria Åström, MD PhD, Elisabeth Ejerblad, MD, Anna Hugosson, MD, Peter L. Johansson, MD PhD, Björn Andréasson, MD PhD

Blood (2014) 124 (21): 1861.

DOI: https://doi.org/10.1182/blood.V124.21.1861.1861

Published: 2014

NARROW

How I treat primary ITP in adult patients who are unresponsive to or dependent on corticosteroid treatment

Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter study

ITP World Impact Survey (I-WISh) 2.0: Further Exploration of the Impact of ITP on Patients

A Phase II Study to Assess the Sustained Response Off Treatment in Patients with ITP Receiving Eltrombopag, Who Had a Previous Insufficient Response to Corticosteroids (TAPER): A Recruitment Update

Magnetic resonance imaging for diagnosis of recurrent ipsilateral deep vein thrombosis

Physicians' and Patients' Perspectives on Treatments in ITP - a Multi-Country Perspective: Results from the ITP World Impact Survey (I-WISh)

Enhanced Responses to Fostamatinib As Second-Line Therapy and in Persistent Immune Thrombocytopenia (ITP) Patients

Safety and Efficacy of the Off-Label Use of Thrombopoietin Receptor Agonists for Immune Thrombocytopenia in Pregnancy: Results from a Multicentre Observational Study

The Psychometric Properties of the ITP Life Quality Index Assessed in a Large Multinational "Real-World" Cohort of Immune Thrombocytopaenia Patients

Rituximab Yielded a Significantly Longer Response Compared to Placebo in Steroid Free Population - a Post Hoc Analysis of the Ritp Study

The Risk of Thromboembolism Associated with Treatment of ITP with Rituximab: Adverse Event Reported in Two Randomized Controlled Trials

Long Term Remission Achieved By Fostamatinib in ITP: A Case Report

Results from the ITP World IMPACT Survey (I-WISh): Patients with Immune Thrombocytopenia (ITP) Experience Impaired Quality of Life (QoL) Regarding Daily Activities, Social Interactions, Emotional Well-Being and Working Lives

Thrombin-Generating Capacity of Microvesicles (MVs) in Patients with Immune Thrombocytopenia (ITP) before and during Treatment with Thrombopoietin-Receptor Agonists (TPO-RA)

Safety of D-Dimer As a Stand-Alone Test for the Exclusion of Deep Vein Thrombosis Compared to Other Strategies

Patients with Immune Thrombocytopenia (ITP) Frequently Experience Severe Fatigue but Is It Under-Recognized By Physicians: Results from the ITP World Impact Survey (I-WISh)

Romiplostim Treatment Pattern of Adult Chronic Immune Thrombocytopenia in Routine Clinical Care in Three Nordic Countries

Long-Term Maintenance of Platelet Responses in Adult Patients with Persistent/Chronic Immune Thrombocytopenia Treated with Fostamatinib: 1-Year Efficacy and Safety Results

Epidemiology of Myeloproliferative Neoplasms in Norway

A Retrospective Cohort Study of Interferon-α Therapy in Myeloproliferative Neoplasms; Adverse Events, Thromboembolic Incidence and Causes of Termination of Therapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only